Screener
Cognex CGNX R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Cognex in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Cognex’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000851205-26-000065
| Line item | Three-months Ended / July 5, 2026 | Three-months Ended / June 29, 2025 | Six-months Ended / July 5, 2026 | Six-months Ended / June 29, 2025 |
|---|---|---|---|---|
| Revenue | $291,263 | $249,093 | $559,700 | $465,129 |
| Cost of revenue | 85,490 | 81,217 | 162,988 | 152,930 |
| Gross profit | 205,773 | 167,876 | 396,712 | 312,199 |
| Research, development, and engineering expenses | 32,391 | 33,102 | 69,416 | 67,829 |
| Selling, general, and administrative expenses | 87,865 | 91,341 | 181,906 | 174,845 |
| Operating income | 85,517 | 43,433 | 145,390 | 69,525 |
| Foreign currency gain (loss) | (862) | (1,503) | (2,207) | (3,956) |
| Investment income | 5,091 | 4,040 | 9,927 | 8,030 |
Item 1. Financial Statements (interim periods unaudited)
FAQ
- What is Cognex's R&D?
- Cognex (CGNX) reported R&D of $32.39M in Q2 2026.
- How has Cognex's R&D changed year-over-year?
- Cognex's R&D decreased by 2.1% year-over-year, from $33.1M to $32.39M.
- What is the long-term trend for Cognex's R&D?
- Over 4 years (2021 to 2025), Cognex's R&D has grown at a 0.7% compound annual growth rate (CAGR), from $135.37M to $138.97M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Cognex's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude